Exciting speaker line-up planned for InterSystems Joined Up Health and Care 2019
The Joined Up Health and Care conference returns for its sixth year on 10th October at The Vox in Birmingham.
The conference will see presentations from Matthew Honeyman, policy researcher at The King’s Fund and Liz Jones, digital project manager at Lincolnshire Sustainability and Transformation Partnership.
It will also explore initiatives such as FHIR – David Hancock, healthcare executive advisor at InterSystems will direct a panel of industry leaders around how FHIR can help the NHS now and in the future. The day will also include presentations on machine learning and artificial intelligence and Dr Yossi Cohen, physician executive at InterSystems will also explore population health and the shift from reactive care to proactive health.
Chris Norton, InterSystems, said: “Every year Joined Up Health and Care attracts influencers from NHS leaders, to technology innovators, media, and crucially people at the heart of delivering our health and care services. Importantly, it has become a stage for sharing best practice so that our partners who are dedicated to delivering the best services for patients, can take away ideas and practical lessons that can be used to drive forward transformation in their own organisations.”
Former NHS Medical Director Sir Bruce Keogh joins Big Health Advisory Board
Former NHS Medical Director, Sir Bruce Keogh, has joined the Advisory Board of digital therapeutics company, Big Health.
The London and San Francisco-based company behind Sleepio, the digital sleep improvement program, has brought Sir Bruce on board to provide strategic advice on expanding its availability within the NHS.
Sir Bruce Keogh, former Medical Director of the NHS in England said “The value of digital therapies is being increasingly recognised, not just because they work when based on sound evidence, but because they are very easily accessible when needed. That’s why I’m pleased to be joining Big Health who have developed Sleepio according the highest standards of clinical evidence and scientific rigour to underpin a proven, effective and safe digital therapy which addresses a remarkably common problem.”
Professor Colin Espie, Founder of Big Health, said “We want to have the best people in healthcare backing us in our mission to help bring millions back to good mental health. Whilst Sleepio is already available via the NHS in some regions, having Sir Bruce as part of the team will help us to reach more people who are seeking improved sleep and help them to achieve better mental and physical wellbeing as a result.”
Isosec announces cloud based authentication platform
Isosec has announced a Web Authentication Platform that will deliver a cloud-only service for any device, any platform, anywhere access.
Health tech marketing and PR agency adds life science knowledge with new hire
Highland Marketing has added to its team with the appointment of Tia Dissanayake, providing additional life science knowledge to the agency.
Tia said “I wanted to move into marketing and communications to help spread that message, and Highland Marketing’s focus on health and health tech made it the perfect fit.”
Mark Venables, CEO, Highland Marketing, said “As health and care becomes more integrated and more digitally mature, we are increasingly being asked to support companies that want to demonstrate how the data they are generating can be used to advance clinical practice, create new digital services, and support cutting-edge research.”
“Tia’s scientific approach will bring an alternative perspective to Highland Marketing and introduce new ideas to the team that will, in turn, support our clients and the organisations and patients they serve.”
Elucid mHealth awarded US patents
Elucid’s Pill Connect system has completed two clinical trials has been granted two patents covering; the dispensing methodology, link to a mobile phone and tracking and recording of each dispense. Three further patents are in progress.
Pill Connect provides prompts to patients and real-time adherence data for both patients and doctors. It uses simple to use smart packaging and a mobile application to support patients and to control, monitor and report medicine use.
James Burnstone CEO of Elucid mHealth “We are delighted with the progress we have made and the interest from so many CROs and pharma companies. Our initial robustness trials, which exceeded 90% successful dispenses and recording of each dispenses remotely, highlighted areas for improvement. We are now confident that the new smart bottle will achieve ≥ 99% reliability.”
